Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$153.0K
11.18K shares
What this filing means
SCHOENBERG MARK plans to sell 11.18K shares of UROGEN PHARMA LTD. valued at approximately $153.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2025ACC: 0001976408-25-000296
Officer· Chief Medical Officer
Since Jan 2019
11.18K
Shares to sell
$153.0K
Approx. market value
3.33K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU
N/A
9/7/2023
3.33KTotal acquired3.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/7/2023 | RSU N/A | 3.33K | — |
| Total | 3.33K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.15K
Market value
$98.6K
7/28/2025
—Completed
Units to sell
5.16K
Market value
$38.0K
6/9/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
871.00
Market value
$16.4K
9/8/2025
Total
Units
11.18K
Value
$153.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/28/2025 | 5.15K | $98.6K | — | Completed |
6/9/2025 | 5.16K | $38.0K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2025 | 871.00 | $16.4K | Nasdaq | Planned |
| Total | 11.18K | $153.0K | ||